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introduction: Achieving a secure airway in rabbits is generally considered more difficult 
than in cats or dogs. Their relatively large tongue, small oropharyngeal cavity and glottis 
limit direct visualization. A rabbit-specific supraglottic airway device (SGAD) may offer 
benefits over blind orotracheal intubation.
animals and methods: Fifteen adult New Zealand white rabbits were randomized to 
SGAD or orotracheal intubation (ETT). All animals were sedated with dexmedetomidine 
(0.1 mg kg−1 IM) and midazolam (0.5 mg kg−1 IM), followed by induction with alfaxalone 
(0.3 mg kg−1 IV). Two CT scans of the head and neck were performed, following seda-
tion and SGAD/ETT placement. The following were recorded: time to successful device 
insertion, smallest cross-sectional airway area, airway sealing pressure, and histological 
score of tracheal tissue. Data were analyzed with a Mann–Whitney test.
results: Two rabbits were excluded following failed ETT. Body masses were similar 
[ETT; n = 6, 2.6 (2.3–4.5) kg, SGAD; n = 7, 2.7 (2.4–5.0) kg]. SGAD placement was 
significantly faster [33 (14–38) s] than ETT [59 (29–171) s]. Cross-sectional area (CSA) 
was significantly reduced from baseline [12.2 (6.9–3.4) mm2] but similar between groups 
[SGAD; 2.7 (2.0–12.3) mm2, ETT; 3.8 (2.3–6.6) mm2]. In the SGAD group, the device tip 
migrated into the laryngeal vestibule in 6/7 rabbits, reducing the CSA. ETT airway seals 
were higher [15 (10–20) cmH2O], but not significant [SGAD; 5 (5–20) cmH2O, p = 0.06]. 
ETT resulted in significantly more mucosal damage [histological score 3.3 (1.0–5.0)], 
SGAD; 0.67 (0.33–3.67).
conclusion: The SGAD studied was faster to place and caused less damage than 
orotracheal intubation, but resulted in a similar CSA.
Keywords: rabbit anesthesia, endotracheal intubation, secure airway, steroid anesthetic, alpha 2 agonists
inTrODUcTiOn
General anesthesia and sedation in rabbits carries a relatively high risk, with an overall incidence of 
death of 1.39% reported, approximately 6–8 times higher than that in cats and dogs (1). A range of 
factors potentially contribute to this increased risk, including difficulty achieving a secure airway, the 
propensity for hypoventilation during anesthesia, and underlying respiratory disease (1–5).
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Orotracheal intubation provides a secure airway by facilitating 
the flow of gas during spontaneous ventilation, allowing intermit-
tent positive pressure ventilation (IPPV), preventing aspiration of 
foreign material into the respiratory tract, and limiting workplace 
pollution with waste anesthetic gas. Achieving atraumatic, timely 
orotracheal intubation is difficult without training and practice and 
is hindered by the oropharyngeal anatomy of rabbits, with their 
relatively large tongues, narrow oropharyngeal cavity, and small 
glottis (5–11). Rabbits may be more susceptible to glottic or tracheal 
injury from endotracheal tubes because of a highly vascularized 
mucosa and submucosa compared to other species (7).
As a result of difficulties achieving orotracheal intubation, it 
is not commonly performed and anesthesia may be induced and 
maintained with a facemask; however, this commonly leads to 
inadequate ventilation (1, 12, 13). Supraglottic airway devices 
(SGADs) designed for humans have been successfully used dur-
ing general anesthesia in rabbits and dogs and have the following 
advantages over orotracheal intubation with an endotracheal 
tube (ETT): rapid insertion by experienced and inexperienced 
operators alike, with a reduced anesthetic induction agent require-
ment, and reduced risk of airway trauma and cardiovascular 
stimulation during insertion (7, 8, 12, 14–16). However, lingual 
cyanosis, gastric tympany, and an incomplete airway seal have 
been reported with the use of human SGAD in rabbits (8, 12, 17). 
Recently, a rabbit-specific device (v-gel, Docsinnovent Ltd., 
London, UK) has been developed, which may help reduce these 
complications (6, 18).
The aim of this study was to assess the performance of this 
rabbit-specific SGAD against blind orotracheal intubation with 
an ETT. Primary outcome measures included time to success-
ful device insertion, cross-sectional airway area, histological 
score, and airway seal. Compared with ETT, we hypothesized 
that the SGAD would be faster to place and maintain a larger 




In a prospective, randomised study design, adult New Zealand 
white rabbits were obtained as surplus stock from the Animal 
Resource Center of the University of Calgary and a commercial 
supplier (Charles River Laboratories, Québec city, QC, Canada, 
n = 12 males, n = 3 females). Rabbits from the commercial supplier 
had a minimum of 1 week to acclimatize before experimentation. 
Rabbits were either group or individually housed (depending on 
location) in an environmentally controlled unit [12 h light/12 h 
dark cycle (lights on at 0730), target temperature between 16 and 
22°C, target humidity between 40 and 50%]. All rabbits were pro-
vided with ad libitum pellets, hay, and water with a small amount 
of fruit and vegetables. Experiments were performed between 
1700 and 2000 hours.
Animals were block randomized to one of the two treat-
ment groups for managing airway and each device type was 
placed by a single investigator: ETT (Daniel S. J. Pang) SGAD 
(Sarah Engbers). These investigators both completed an online 
training program provided by the manufacturer and practical 
experience was gained with two rabbits scheduled for euthanasia. 
Investigators could not be blinded to group assignment, with 
the exception of the veterinary pathologist (Cameron Knight), 
who performed necropsies off-site. Animals were fasted for 
approximately 2 h before the experiment. Physical examinations 
(cardiothoracic auscultation, examination of musculoskeletal 
system, and integument) were performed immediately before 
each experiment. Exclusion criteria included any indication of 
systemic illness resulting in assigning an American Society of 
Anesthesiologists physical classification status >2.
sedation
Animals were sedated with dexmedetomidine (0.1 mg kg−1, Dex- 
domitor, Zoetis, Kirkland, QC, Canada) and midazolam (0.5 mg kg−1, 
Midazolam Sandoz, Sandoz Canada, Boucherville, QC, Canada) 
delivered intramuscularly as a single injection in the epaxial muscu-
lature. Ten minutes later, animals were placed in sternal recumbency 
on the CT scan table, provided oxygen by facemask (1.5 L min−1) 
and cannulas (22 gauge 1″, BD Insyte, Becton Dickinson Infusion 
therapy systems Inc., Sandy, UT, USA) placed in the auricular 
vein (IV) and artery. A baseline CT scan (Toshiba Aquilon 8 slice, 
Markham, ON, Canada) was performed under sedation following 
instrumentation, followed by a second scan after ETT or SGAD 
placement. Scans were performed by a board-certified radiologist 
(Nicolas Rousset), with the scan margins ranging from the rostral 
margin of the nose to the thoracic inlet.
induction of anesthesia and Device 
insertion
Following the baseline CT scan, invasive systemic arterial blood 
pressure (BP), ECG, and saturation of arterial hemoglobin with 
oxygen (pulse oximetry probe on the prepuce or vulva) moni-
toring began (LifeWindow LW6000V, Digicare Animal Health, 
Boynton Beach, FL, USA). General anesthesia was induced with 
alfaxalone (0.3  mg  kg−1 IV, Alfaxan, Jurox, Rutherford, NSW, 
Australia). The SGAD size was chosen based on body mass as 
per the manufacturer’s recommendations. Where an animal fell 
between sizes, the larger SGAD was selected. An insertion attempt 
began 30 s after completing alfaxalone injection. Each animal in 
the SGAD group was positioned in sternal recumbency with its 
tongue exteriorized and the lubricated SGAD (lubricating spray, 
Docsinnovent Ltd., London, UK) inserted into the oropharynx 
until either resistance was encountered, or the incisors were 
within 1–2 cm of the device’s fixation tabs. Acceptable placement 
was confirmed with a mainstream capnograph attached to the 
SGAD (Masimo EMMA Capnograph with pediatric sample 
chamber, Masimo, Danderyd, Sweden) and visualization of six 
rectangular waveforms. Criteria for rescue intubation with ETT 
for the SGAD group were defined as: lingual cyanosis that did 
not resolve with repositioning the SGAD or tongue, or three 
unsuccessful insertion attempts (no capnograph trace observed).
Orotracheal intubations were performed using a blind tech-
nique (19). Endotracheal tube size (2–3.5 mm ID, Sheridan/CF, 
Teleflex Medical Canada Inc., Markham, ON, Canada) was selected 
based on investigator experience. Each animal was positioned 
in sternal recumbency with the head and neck hyperextended. 
FigUre 1 | representative midline sagittal image showing the inserted supraglottic airway device (sgaD). The basihyoid bone (BH), thyroid cartilage (TC), 
and SGAD tip are labeled. The distance between the caudal edge of BH and rostral edge of TC is the distance A–B and was used to assess anatomical variation 
between rabbits. Insertion depth of the SGAD was measured by the distance A–C, the distance between the tip of the SGAD and the caudal edge of the BH.
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A single dose of lidocaine (12  mg lidocaine per metered dose, 
Lidodan, Odan Laboratories Ltd., Montreal, QC, Canada) was 
sprayed into the caudal oropharyngeal area 30 s before attempting 
ETT. Confirmation of ETT was with a mainstream capnograph, 
as described for SGAD placement. For both SGAD and ETT, 
the number of insertion attempts and total time for insertion 
were recorded. Insertion time was from the moment the SGAD 
or endotracheal tube passed the incisors until the first of six 
capnograph waveforms was observed. If capnograph waveforms 
were not observed following SGAD placement, adjustments were 
made by repositioning slightly rostrally or caudally. The number 
of attempts during intubation with each device was recorded, 
with an “attempt” representing the withdrawal of the device out 
of the mouth before re-inserting or changing to a different size. 
Airway devices were secured behind the ears with a bandage tie.
Monitoring
Baseline systemic arterial BPs were recorded immediately before 
induction of general anesthesia. Beginning immediately after the 
insertion of the airway device, physiologic data (BP, heart, and 
respiratory rates, SpO2) were collected and recorded every 30 s 
for 5 min, and at 15 min post-insertion. Additionally, the highest 
systemic systolic arterial BP observed during device insertion 
was recorded (from video-recording of the physiologic moni-
tor). At 10 min, the second CT scan was performed. At 15 min, 
the concentration of isoflurane measured from a sampling line 
placed approximately 5 cm from the mouth was recorded, and 
the airway seal was tested by closing the adjustable pressure 
limiting valve on the anesthetic breathing system and squeezing 
the reservoir bag. Peak inspiratory pressures were increased in 
5 cmH2O increments, between 5 and 20 cmH2O, until a leak was 
heard (or 20 cmH2O achieved). This leak test was done by the 
same investigators (Sarah Engbers and Daniel S. J. Pang) for all 
animals. Occurrences of lingual cyanosis or airway obstruction 
(audible wheeze during respiratory cycle or irregular capnograph 
trace) were recorded. In the last nine animals (SGAD n = 4, ETT 
n =  5), an arterial blood sample was collected from the intra-
arterial cannula 30 min after device placement and analyzed for 
blood gases and electrolytes (CG8+ cartridges, iSTAT Portable 
Clinical Analyzer, Heska Corporation, Fort Collins, CO, USA). 
General anesthesia was maintained for 60  min (from time of 
induction) with isoflurane (1% vaporizer setting) carried in oxy-
gen (1 L min−1) through a non-rebreathing system (coaxial Bain). 
All animals were euthanized with an overdose of IV sodium 
pentobarbital while anesthetized at the end of the experiment.
cT image reconstruction and 
Measurements
CT scans were reconstructed using a multi-planar reconstruction 
tool on OsiriX software (v 7.0.1, Pixmeo, Geneva, Switzerland).
All measurements were taken three times by a board-certified 
veterinary radiologist (Nicolas Rousset) and averaged for analy-
sis. The midline sagittal view of each SGAD rabbit post-device 
placement was used to measure the following distances: (1) 
distance between the caudal edge of the basihyoid bone (BH) to 
the rostral edge of the thyroid cartilage (TC) (A–B, Figure  1), 
(2) the distance from the caudal edge of the BH to the tip of the 
SGAD (A–C, Figure 1), and (3) the distance between the SGAD 
tip and the rostral edge of the TC (B–C, Figure 1). Confirmation 
of whether the SGAD tip entered the upper esophageal sphincter 
was recorded in each instance, as well as the anatomical location 
of the SGAD tip. Transverse images from before and after device 
placement were compared to determine the narrowest region of 
the upper airway. In the SGAD group, the site of the narrowest 
section was also measured relative to the SGAD tip in order to 
determine any contribution from the device to airway narrowing. 
TaBle 1 | histological scale used to score damage to mucosal and 
submucosal layers of the larynx and cranial third of the trachea.
Mucosa submucosa score
Normal Normal 0
Mild focal erosion with little or no 
leukocytic infiltration
Minimal to mild locally 
extensive congestion
1
(Multi)focal erosion or ulceration with 
edema of lamina propria, moderate 
mixed leukocytic infiltration, and 
hemorrhage
Moderate diffuse congestion 
and mild perivascular edema
2
Extensive erosion or ulceration with 
marked mixed leukocytic infiltration, 
cellular debris, hemorrhage, and 
possibly surface exudate
Moderate diffuse congestion 
and edema with or without 
hemorrhage, and leukocyte 
infiltration associated with 
overlying ulcer or erosion
3
The scale has been modified from that of Phaneuf et al. (7).
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resUlTs
animals
Two rabbits were excluded from the ETT group, one due to failure 
to achieve orotracheal intubation and the other due to prolonged 
intubation resulting from fecal matter in the oropharynx (21). 
CT scans were not performed in two rabbits (both from the ETT 
group) due to unavailability of the CT scanner. In these cases, the 
anesthetic duration was matched to the full procedure and other 
data were collected as planned. All rabbits in the SGAD group 
had a device placed. Final group sizes were: ETT, n = 6; SGAD, 
n = 7. Rabbits ranged in age from 3 to 12 months. There were no 
significant differences in body mass between groups: ETT; 2.6 
(2.3–4.5) kg, SGAD; 2.7 (2.4–5.0) kg (p = 0.38, 95% CI −2.3 to 
1.8). All rabbits appeared healthy on physical examination and 
were assigned an American Society of Anesthesiologists physical 
classification status of 1. The endotracheal tubes used in the ETT 
group ranged from 2 to 3.5 mm ID: 2 mm, n = 2; 2.5 mm, n = 1; 
3 mm, n = 1; 3.5 mm, n = 2. Three sizes of SGAD were used: R3, 
n = 4; R4, n = 1; and R5, n = 2.
cT imaging
Airway anatomy was similar between groups. The distance between 
the caudal edge of the BH and the rostral edge of the TC did not 
differ significantly (p =  0.16, 95% CI −6.7 to 1.3): SGAD, 16.2 
(13.2–20.3) mm; ETT, 14.5 (12.7–15.8) mm (distance A–B, Figure 1).
In most cases (6/7 rabbits), placement of the SGAD resulted 
in the tip of the device deviating ventrally to be positioned within 
the laryngeal vestibule (n =  6, Figures  2 and 3). This resulted 
in a reduction in the CSA of the airway. The CSA before device 
placement was smallest within the nasopharynx in nine rabbits 
and within the larynx in two rabbits, with no significant dif-
ference between groups (p = 0.78, 95% CI −2.3 to 3.7 mm2) so 
that baseline CSA was pooled. The CSA of the narrowest point 
decreased significantly between the baseline CT scan [CSA, 
12.2 (6.9–13.4)  mm2] and placement of the SGAD [CSA, 2.7 
(2.0–12.3) mm2, p = 0.003, 95% CI 4.1 to 10.3] and ETT [CSA, 
3.8 (2.3–6.6) mm2, p = 0.002, 95% CI 4.6–10.6, Figure 4]. There 
was no significant difference in CSA between ETT and SGAD 
(p = 0.93, 95% CI −5.7 to 3.9). The site of the smallest CSA in the 
SGAD group was located within the device tip [4.2 mm (range 
3.2–5.2) from the tip extremity] at an average of 5.3 mm (range 
2.9–7.9) caudal to the rostral edge of the TC, so that the smallest 
CSA was formed by the SGAD dorsally and the rabbit’s airway 
ventrally (Data Sheet S1 in Supplementary Material). In the ETT 
group, a uniform CSA was created by the endotracheal tube.
Device Placement
Device insertion time was shorter and more consistent (narrower 
range) for the SGAD [33 (14–38)  s] than ETT [59 (29–171)  s, 
p = 0.02, 95% CI 12–133, Figure 5]. The number of attempted device 
placements did not differ between groups (SGAD: 1 attempt, n = 4; 
2 attempts, n = 3. ETT: 1 attempt, n = 4; 2 attempts, n = 2. p > 0.99, 
95% CI −1 to 1). The median airway seal was higher in the ETT 
group [15 (10–20) cmH2O], but there was no statistical difference 
compared to the SGAD group [5 (5–20) cmH2O, p = 0.06, 95% CI 
The cross-sectional area (CSA) of the narrowest point was meas-
ured. For the ETT group, the luminal CSA was measured.
necropsies
Necropsies were performed on all rabbits within 2 h of euthanasia 
by a board-certified veterinary pathologist (Cameron Knight) 
according to a standardized method (20). The tongue, pharynx, 
larynx, and trachea were collected and fixed in 10% neutral-
buffered formalin. Tissues were prepared routinely for histologic 
evaluation and stained with hematoxylin and eosin. For each 
rabbit, three to four representative transverse sections from each 
of the following locations were examined histologically: (1) larynx 
at the level of the vocal folds, (2) trachea immediately caudal to the 
larynx, and (3) trachea 1 cm caudal to the larynx. The mucosal and 
submucosal layers in each section were evaluated according to a 
scoring system modified from a previously published study (7). 
The modification involved removing scoring criteria that reflected 
chronic injury from repeated endotracheal intubation over several 
weeks, which were not applicable in the current study. The scoring 
criteria used in this study are listed in Table 1. Scores for sections 
from the same region were averaged and a total score (/6) was 
calculated by summing the mucosal and submucosal scores.
statistics
Commercial software was used for statistical analyses (Prism v 7.0a, 
GraphPad Software, La Jolla, CA, USA). Data were tested for normal 
distribution with a D’Agostino and Pearson normality test. Non-
parametric analyses were used if data were not normally distributed 
or sample sizes were too small for the normality test. Mann–Whitney 
tests were used to make the following comparisons between groups: 
body mass, anatomical distances, cross-sectional airway areas, device 
insertion time, airway seal, percentage changes in systolic BP during 
device insertion, arterial blood sample parameters, and histological 
scores. A Wilcoxon matched pairs test was used to compare changes 
in systolic arterial BP over time. Two-way ANOVA was applied to 
systemic arterial BPs, heart rate, respiratory rate, and expired CO2 
data, followed by a Bonferroni post  hoc test if main effects were 
significant. A p value < 0.05 was considered significant. Data are pre-
sented as mean ± SD and median (range). 95% confidence intervals 
(95% CI) for mean or median differences are provided as available.
FigUre 2 | representative sagittal cT images of rabbits’ heads.  
(a) 2.7 kg rabbit before airway device placement. (B) 2.7 kg rabbit with an 
endotracheal tube (2.5 mm ID) inserted into the trachea. (c) 2.7 kg rabbit 
[same animal as panel (a)] with a supraglottic airway device (SGAD) (SGAD, 
size R3) inserted. In panel (B), the endotracheal tube is visible passing 
through the caudal oropharynx, larynx and trachea. Rostral to this, it lies 
outside the plane of view. In panel (c), the tip of the SGAD enters the larynx, 
reducing the cross-sectional area (Figure 4).
FigUre 3 | representative transverse cT images of the rabbits depicted in Figure 2, where (a) is before airway device placement, (B) is with the 
endotracheal tube inserted, and (c) is with the supraglottic airway device (sgaD) in situ. The image in (c) shows the narrowest cross-sectional area of the 
airway, including the SGAD tip. Panels (a,B) represent the same anatomical level as (c).
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0–15, Figure 6]. A single animal in the SGAD group had an airway 
seal of 20 cmH2O. In this animal, loss of the capnograph trace indi-
cated respiratory obstruction, so the SGAD was retracted until the 
trace returned and the airway seal test performed after reposition-
ing. The median SGAD insertion depth was 20.7 (11.1–26.5) mm 
(distance A–C, Figure 1), and the rabbit in which the SGAD was 
adjusted had the shortest insertion distance (11.1 mm), so that the 
device tip did not enter the larynx. Isoflurane was not detected, nor 
lingual cyanosis observed, in any rabbit. Lingual cyanosis was not 
observed in any rabbit of either treatment group.
histological evaluation
The ETT group was found to have significantly more damage to 
tracheal mucosa and submucosa [3.3 (1.0–5.0)] than the SGAD 
group [0.67 (0.33–3.67), p = 0.03, 95% CI 0–3.3, Figure 7].
Physiologic Variables
There was a systematic, albeit non-significant, difference in 
systemic arterial BP between groups, with higher BPs observed 
in the SGAD group (systolic, p = 0.45; diastolic, p = 0.11; mean, 
p = 0.17; Data Sheet S2 in Supplementary Material). The percent-
age change in peak systolic arterial BP observed during placement 
did not differ between each group and baseline (SGAD, p = 0.3, 
95% CI −5.8 to 3.9; ETT, p = 0.16, 95% CI −13.2 to 1.1). Between 
groups, ETT [3.2 (−1.1 to 13.2)%] showed a wider range of per-
centage change in peak systolic BP than SGAD [1.0 (−3.9 to 5.8)%] 
though the median difference was not significant (p = 0.45, 95% 
CI −11.9 to 2.1, Figure 8). There were no significant main effects 
between treatment groups for heart rate (p = 0.32), respiration 
rate (p = 0.22), and expired CO2 (p = 0.74), though heart and 
respiratory rates tended to be higher in the SGAD group (Data 
Sheet S2 in Supplementary Material). One rabbit in each group 
had a single SpO2 reading <90% (SGAD, 89%; ETT, 88%; both 
were recorded immediately following device insertion).
Blood gases and electrolytes
No significant differences in the following variables were 
observed: pH, PaO2, PaCO2, BE, HCO3, SaO2, Na, K, iCa, hema- 
tocrit, hemoglobin (Table S1 in Supplementary Material). 
Hypercapnea was present in both treatment groups: SGAD; 65.1 
(54.0–75.1) mmHg, ETT; 51.8 (41.2–67.8) mmHg.
DiscUssiOn
The findings of this study show that, in comparison with oro-
tracheal intubation using a blind technique, the rabbit-specific 
SGAD studied is rapid to place and causes minimal trauma to the 
upper airway. As with orotracheal intubation, the SGAD can be 
used to successfully maintain general anesthesia in rabbits.
General anesthesia and sedation in rabbits carries an unac-
ceptably high mortality rate compared with dogs and cats. A 
study of 8,209 rabbits identified respiratory and cardiovascular 
or respiratory causes (where the initial problem could not be 
FigUre 8 | scatter plot of percentage change in systolic arterial 
blood pressure for the supraglottic airway device (sgaD) and 
endotracheal intubation (eTT) groups during placement of each 
device. p = 0.2. Horizontal line is median.
FigUre 7 | scatter plot of histopathology scores for the supraglottic 
airway device (sgaD) and endotracheal intubation (eTT) groups. 
*p = 0.03. Horizontal line is median. Score range is 0–6, with increasing 
scores reflecting increasing submucosal and mucosal damage.
FigUre 6 | scatter plot of the pressure at which a leak was detected 
when testing the airway seal in the supraglottic airway device (sgaD) 
and endotracheal tube (eTT) groups. *p = 0.02. Horizontal line is median.
FigUre 5 | scatter plot of time to insert the supraglottic airway 
device (sgaD) and endotracheal tube (eTT). *p = 0.02. Horizontal line is 
median.
FigUre 4 | scatter plot of cross-sectional areas (csa) at the 
narrowest point of the upper airway before (baseline) and after 
supraglottic airway device (sgaD) or endotracheal tube (eTT) 
placement. CSA of pre-intubation versus SGAD, *p = 0.003. CSA of 
pre-intubation versus ETT, *p = 0.001. Horizontal line is median.
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discerned) as the most frequent causes (13 and 23%, respectively) 
(1). Underlying respiratory disease, respiratory depression during 
anesthesia and absence of a secure airway have been suggested as 
contributing factors (1–5).
Providing a secure airway and the ability to support ventila-
tion pose a challenge to anesthetists inexperienced with rabbits 
and when blind orotracheal intubation is attempted. Achieving 
orotracheal intubation is difficult without training and practice 
(8, 22). Compared with dogs and cats, direct visualization without 
appropriate equipment is hindered by a relatively large tongue, 
narrow oropharyngeal cavity, and small glottis (5–11). When 
using a blind intubation technique, multiple intubation attempts, 
intubation times of several minutes, and the occasional failure 
are commonly reported (8, 14, 22). Our findings reflect this, with 
improved consistency in the time taken to secure an airway 
with the SGAD, in which the longest time was 38 s, compared with 
171 s in the ETT group. This difference is magnified when the case 
of failed intubation is considered. This advantage of the SGAD is 
particularly important, as the time taken to achieve orotracheal 
intubation by novices can be substantially longer (240–360 s in one 
study) than the range reported here (8). Furthermore, successful 
orotracheal intubation may require multiple attempts, potentially 
contributing to postoperative morbidity and mortality. Though 
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the number of attempts did not differ between SGAD and ETT, 
our results show that even one to two attempts with ETT resulted 
in measurable trauma to the tracheal tissues. Similar findings 
have been reported in horses and our findings are consistent with 
those of Phaneuf et  al., where histologic changes were reported 
after a single intubation event (the number of attempts was not 
reported) using both cuffed and uncuffed endotracheal tubes 
(7, 23). Since animals were euthanized at the end of our study, the 
consequences of the histologic changes are unknown; however, 
morbidity and mortality have been reported following apparently 
uneventful blind orotracheal intubations (7, 24). One rabbit in 
the SGAD group had a higher histological score, of 3.67, than the 
rest of the group. The location of the damaged mucosa was on the 
dorsal wall of the airway, beginning 10 mm caudal to the basihyoid 
and extending approximately 40 mm caudally. The cause of this 
lesion is unclear as the SGAD tip did not extend this far caudally.
With regular use, it is possible that the time to place the SGAD 
may be reduced further, and recorded times in this study were 
increased because they included observing a waveform on the 
capnograph (18). Securing an airway in a reasonable time allows 
management of hypoventilation and control of PaCO2 and PaO2.
Hypoventilation is a common occurrence at induction and 
during general anesthesia in rabbits (2–4, 12). A frequent alterna-
tive to orotracheal intubation is the use of a facemask. This has 
several disadvantages, including lack of a secure airway, potential 
workplace pollution, and the inability to support ventilation. 
The use of a facemask does not allow IPPV to be performed and 
increases mechanical deadspace, both of which contribute to 
hypercapnea (in excess of 100 mmHg), respiratory acidosis, and 
increased risk of hypoxemia (12). When a SGAD is placed, as in 
this study, hypercapnea may still occur without IPPV (12). As 
IPPV was not instituted in this study, it was not possible to assess 
if the relatively low airway sealing pressures generated were suf-
ficient; however, they did prevent measurable levels of isoflurane 
at a distance comparable to the head of an operator during dental 
procedures. Higher sealing pressures were identified in a feline 
version of the SGAD, with 7/15 animals maintaining a seal up 
to a peak inspiratory pressure of 16 cmH2O (25). A limitation of 
the present study was that repositioning of the SGAD to try and 
achieve a higher sealing pressure was not done.
The tip of the SGAD studied is designed to enter the upper 
esophagus during placement and act as a seal to ensure gas flow 
is directed in to the airways. Our results suggest that this does not 
occur. Explanations for this discrepancy may include placement 
technique, equipment, and anatomical differences. Both authors 
involved in device placement completed an online training course 
available on the manufacturer’s website as well as successfully 
performing several SGAD placements in two rabbits scheduled 
for euthanasia. During product development, the device designer 
suggested that a degree of experience is necessary for optimal 
placement in combination with capnograph trace evaluation 
(18). High fresh gas flow rates, large sampling chambers, and slow 
rise times can distort capnograph traces, particularly in smaller 
animals, though the gas flow rate used was comparable to that 
previously described in rabbits (1.5–2 L min−1), a small sample 
chamber (dead space volume of 1  mL) was used and the rise 
time of the capnograph is reported as <60 ms (for 10–90% step 
change). Optimization of SGAD placement by confirming clear 
breath sounds with a stethoscope placed on the larynx has also 
been suggested (12). Training with an experienced operator may 
have improved placement though the high incidence of SGAD 
tip deviation toward the larynx suggests that device material or 
shape were a contributing factor. SGAD size was selected based 
on manufacturer guidelines. All rabbits in this study were of the 
same breed and while it is unknown if this breed was included 
during device design, airway management with this SGAD has 
been successful in this breed in other studies (14, 15).
Laryngoscopy and endotracheal intubation are associated with 
a hemodynamic response (tachycardia and arterial hypertension) 
in humans, with associated morbidity and mortality from arrhyth-
mias, intracranial hemorrhage, and elevated intracranial pressure 
(26–28). The use of SGAD in humans reduces this response and 
while our data are inconclusive, this deserves further study (29).
In conclusion, these results show the rabbit-specific SGAD 
studied to be consistently faster to place and to cause less trauma 
to laryngeal and tracheal tissue than a blind orotracheal intuba-
tion technique. The SGAD was capable of maintaining general 
anesthesia, though the presence of hypercapnea underlines the 
importance of the option to provide IPPV.
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